Technology
Health
Pharmaceutical

Taro

$81.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.78 (-0.95%) As of 1:55 PM EDT today
-$0.78 (-0.95%) Today

Why Robinhood?

You can buy or sell Taro and other stocks, options, ETFs, and crypto commission-free!

About TARO

Taro Pharmaceutical Industries Ltd., also called Taro, is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Read More The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Employees
1,464
Headquarters
Haifa Bay, Haifa
Founded
1950
Market Cap
3.17B
Price-Earnings Ratio
11.40
Dividend Yield
0.00
Average Volume
41.26K
High Today
$82.55
Low Today
$81.52
Open Price
$81.97
Volume
12.17K
52 Week High
$109.42
52 Week Low
$76.93

Collections

Technology
Health
Pharmaceutical
Manufacturing
Advertising and Marketing
Business Services
Asia (Non-China)
Asia

TARO Earnings

$1.37
$1.69
$2.01
$2.33
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
$1.96 per share
Actual
$1.72 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.